文献速递呼吸危重症与机械通气

膈肌无力或可解释COVID-19出院15个月后的劳力性呼吸困难

Diaphragm Muscle Weakness Might Explain Exertional Dyspnea 15 Months after Hospitalization for COVID-19.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

出院15个月时约三分之二患者存在中度或重度劳力性呼吸困难,但肺功能和超声心动图未见明显异常。膈神经磁刺激后的单收缩跨膈压显著低于健康对照,且与呼吸困难严重程度相关,提示膈肌无力是持续呼吸困难的相关因素。

要点

  • COVID-19住院后15个月,约三分之二患者仍有中度或重度劳力性呼吸困难。
  • 膈神经磁刺激单收缩跨膈压显著低于健康对照,且不依赖初始疾病严重程度。
  • 单收缩跨膈压与劳力性呼吸困难严重程度显著相关,肺和心脏功能正常者亦如此。

核心结论

  • COVID-19住院后15个月存在膈肌无力,即使未接受机械通气的患者亦然,且该无力与劳力性呼吸困难相关。
  • 研究提示膈肌无力可解释肺和心脏功能正常的COVID-19后患者持续呼吸困难。

研究设计与样本

  • 评估包括肺功能检查、6分钟步行试验、超声心动图、颈磁刺激膈神经根后单收缩跨膈压及膈肌超声,并与健康对照组比较。
  • 临床试验注册号NCT04854863。

主要发现

  • 出院15个月时约三分之二患者存在中度或重度劳力性呼吸困难。
  • 未检测到显著的肺功能或超声心动图异常。
  • 机械通气患者单收缩跨膈压14±8 vs 对照21±3 cm H2O(P=0.02);非机械通气患者15±8 vs 对照21±3 cm H2O(P=0.04)。
  • 单收缩跨膈压与劳力性呼吸困难严重程度显著相关(P=0.03)。

临床怎么用

  • 对COVID-19后持续劳力性呼吸困难而肺功能和心脏评估正常的患者,应考虑评估膈肌功能。
  • 膈肌无力可见于未接受机械通气者,不应仅以初始疾病严重程度判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Dyspnea is often a persistent symptom after acute coronavirus disease (COVID-19), even if cardiac and pulmonary function are normal. Objectives: This study investigated diaphragm muscle strength in patients after COVID-19 and its relationship to unexplained dyspnea on exertion. Methods: Fifty patients previously hospitalized with COVID-19 (14 female, age 58 ± 12 yr, half of whom were treated with mechanical ventilation, and half of whom were treated outside the ICU) were evaluated using pulmonary function testing, 6-minute-walk test, echocardiography, twitch transdiaphragmatic pressure after cervical magnetic stimulation of the phrenic nerve roots, and diaphragm ultrasound. Diaphragm function data were compared with values from a healthy control group. Measurements and Main Results: Moderate or severe dyspnea on exertion was present at 15 months after hospital discharge in approximately two-thirds of patients. No significant pulmonary function or echocardiography abnormalities were detected. Twitch transdiaphragmatic pressure was significantly impaired in patients previously hospitalized with COVID-19 compared with control subjects, independent of initial disease severity (14 ± 8 vs. 21 ± 3 cm H2O in mechanically ventilated patients vs. control subjects [P = 0.02], and 15 ± 8 vs. 21 ± 3 cm H2O in nonventilated patients vs. control subjects [P = 0.04]). There was a significant association between twitch transdiaphragmatic pressure and the severity of dyspnea on exertion (P = 0.03). Conclusions: Diaphragm muscle weakness was present 15 months after hospitalization for COVID-19 even in patients who did not require mechanical ventilation, and this weakness was associated with dyspnea on exertion. The current study, therefore, identifies diaphragm muscle weakness as a correlate for persistent dyspnea in patients after COVID-19 in whom lung and cardiac function are normal. Clinical trial registered with www.clinicaltrials.gov (NCT04854863).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Regmi B, Friedrich J, Jörn B, et al. Diaphragm Muscle Weakness Might Explain Exertional Dyspnea 15 Months after Hospitalization for COVID-19. Am J Respir Crit Care Med. 2023. PMID: 36596223. doi:10.1164/rccm.202206-1243OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。